North Rock Partners, LLC Biogen Inc. Call Options Transaction History
North Rock Partners, LLC
- $3.4 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BIIB
# of Institutions
1,043Shares Held
132MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.62 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.39 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.2 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.13 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$727 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...